fenofibric acid capsule, delayed release
a-s medication solutions - choline fenofibrate (unii: 4bmh7izt98) (fenofibric acid - unii:bgf9mn2hu1) - fenofibric acid delayed-release capsules are indicated as adjunctive therapy to diet to reduce triglycerides (tg) in patients with severe hypertriglyceridemia. improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacological intervention. markedly elevated levels of serum triglycerides (e.g. > 2,000 mg/dl) may increase the risk of developing pancreatitis. the effect of fenofibric acid delayed-release capsules therapy on reducing this risk has not been adequately studied. fenofibric acid delayed-release capsules are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (ldl-c), total cholesterol (total-c), triglycerides (tg), and apolipoprotein b (apo b), and to increase high-density lipoprotein cholesterol (hdl-c) in patients with primary hypercholesterolemia or mixed dyslipidemia. fenofibrate at a dose equivalent to 135 mg of fenofibric acid delayed-release capsules did not reduce coronary heart disease
cardalis- spironolactone and benazepril hydrochloride tablet, chewable
ceva sante animale - spironolactone (unii: 27o7w4t232) (spironolactone - unii:27o7w4t232), benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - cardalis is indicated with concurrent therapy (e.g. furosemide, etc.) for the management of clinical signs of mild, moderate, or severe congestive heart failure in dogs due to atrioventricular valvular insufficiency (avvi). do not administer cardalis in conjunction with non-steroidal anti-inflammatory drugs (nsaids) in dogs with renal insufficiency. do not administer cardalis to dogs with hypoadrenocorticism (addison’s disease), hyperkalemia, or hyponatremia. do not administer cardalis to animals with known hypersensitivity to ace inhibitors or spironolactone.
hemax- ascorbic acid, dl-alpha tocopheryl acetate, l-5-methyltetrahydrofolate calcium, cyanocobalamin, biotin, carbonyl iron, cu
pronova corporation - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (biotin - unii:6so6u10h04), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l) -
maxfe- magnesium ascorbate, l-5 methyltetrahydrofolate calcium, cyanocobalamin, biotin, carbonyl iron, ferrous bisglycinate chel
pronova corporation - magnesium ascorbate (unii: 0n1g678593) (ascorbic acid - unii:pq6ck8pd0r), levomefolate calcium (unii: a9r10k3f2f) (levomefolic acid - unii:8s95dh25xc), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (unii: 6so6u10h04) (biotin - unii:6so6u10h04), ferrous bisglycinate (unii: sfw1d987qv) (ferrous cation - unii:gw89581owr), zinc glycinate (unii: 681vjx72fe) (zinc cation - unii:13s1s8sf37) -
preg-ci time release capsule
advanced chemical industries limited - carbonyl iron + folic acid + zinc - capsule - 50 mg + 500 mcg + 22.5 mg
feropreg tr capsule
amico laboratories ltd. - carbonyl iron + folic acid + zinc - capsule - 50 mg + 500 mcg + 22.5 mg
feofol cl capsule
eskayef pharmaceuticals ltd. mirpur. - carbonyl iron + folic acid - capsule - 50 mg + 500 mcg
feofol ci capsule
eskayef pharmaceuticals ltd., tongi,gazipur - carbonyl iron + folic acid - capsule - 50 mg + 500 mcg
preneed-ci capsule
incepta pharmaceuticals ltd. - carbonyl iron + folic acid + zinc - capsule - 50 mg + 500 mcg + 22.5 mg
zifonyl capsule
kumudini pharma ltd. - carbonyl iron + folic acid + zinc - capsule - 50 mg + 500 mcg + 22.5 mg